Select each of the providers in the first column to see some of the issues related to Meaningful Use and how they were addressed for both Stage 1 and Stage 2. Then select the space in each column to the right of the provider to see what the provider did and still needs to do.
Select CLOSE to continue.
How do I transition the care of my patients to other providers?
How do hospitals provide structured electronic lab results to ambulatory providers?
I had to create summary documents as part of the transition of care for my patients. I could either send them directly to the receiving provider or send them with the patient, but they had to include the required data elements of problem list, medication list, and medication allergies.
We didn’t have to worry about this requirement in the first stage. We implemented a lab interface in preparation for future use, but the local interface we use to connect to an Eligible Provider (EP) isn’t reliable.
I still need to provide a summary document as part of the transition of care, however I need to pay more attention to the data captured during an encounter. The summary must include, at a minimum, the three required data elements (medications, medication allergies, problems) and must be sent electronically (for 10% of transitions) through the CEHRT. New content standards have been introduced, for both the export and the import (consumption) of information into the CEHRT. These additional requirements will impose workflow changes.
We will need to upgrade our system. Since the content standards are new, and we’ve used our own local lab test codes with our in house lab system, the requirement to use Logical Observation Identifiers, Names and Codes (LOINC) and Systemized Nomenclature of Medicine (SNOMED) codes for lab tests and test results may be a challenge to both our system and our technicians. This change will require significant mapping of our internal codes to LOINC. It’s possible that we will have to call in a third party to do this mapping for us.